COMP <GO>
ECVT vs FCX // PIOTROSKI F-SCORE QUALITY
Ecovyst Inc. (NYSE) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: ECVT 4
— FCX 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: FCX
LAST: $10.12 (-1.17%) • MKT CAP: $1.12B
piotroski-score
6/9
LAST: $62.47 (-5.55%) • MKT CAP: $94.98B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECVT VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECVT | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.80% | 26.10% | -4.30 | FCX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.40% | 21.50% | -15.10 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.6x | 13.4x | -2.80 | ECVT | /valuation <GO> |
| Free Cash Flow Yield | 6.24% | 4.71% | +1.53 | ECVT | /fcf-yield <GO> |
| Operating Margin | 9.00% | 25.90% | -16.90 | FCX | /operating-margins <GO> |
| Net Profit Margin | -9.80% | 8.80% | -18.60 | FCX | /net-margins <GO> |
| Revenue Growth (YoY) | 20.90% | 0.10% | +20.80 | ECVT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.91% | -0.91 | FCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.68 | 3.08 | -1.40 | FCX | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | 7/9 | -1.00 | FCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.6 | 43.5 | +10.10 | ECVT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 40.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.12B | $94.98B | -$93.86B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECVT REV | FCX REV | ECVT GROSS % | FCX GROSS % | ECVT FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $723.5M | $25.19B | 21.8% | 26.1% | $69.9M | $4.48B |
| FY 2024 | $598.3M | $25.17B | 27.3% | 29.3% | $94.3M | $6.03B |
| FY 2023 | $584.8M | $22.70B | — | — | $137.6M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECVT // BETA —
FCX // BETA 0.95